Latest Edwards Lifesciences Corp (EW) Headlines
Blood and Cardiac Monitoring Devices Market Assessment Report - Global Size, Share, Competitive Landscape, Future Prospects and Forecast from 2013-2019
M2 - Thu Mar 13, 3:48AM CDT
Research and Markets (http://www.researchandmarkets.com/research/vzjflp/blood_and_cardiac) has announced the addition of the "Blood and Cardiac Monitoring Devices Market Assessment Report - Global Size, Share, Competitive Landscape, Future Prospects and Forecast from 2013-2019" report to their offering. According to the report the global blood and cardiac monitoring devices market was worth $13.6 billion in 2012 and is expected to reach $20.5 billion in 2019, growing at a CAGR of 6.0% from 2013 to 2019. The market for blood monitoring devices is segmented into blood pressure monitors, blood glucose monitors, blood gas analyzers and blood cholesterol monitors. In 2012, the market for blood glucose monitors accounted for the largest share by revenue of the total market at more than 70%. This is attributed mainly to the consistent technological up-gradations in product design followed by the alarming rise in diabetic population and sedentary lifestyles. However, the blood pressure monitors market is expected to record the highest growth during the forecast period owing to the rising prevalence and incidence rate of hypertension and increased awareness about regular monitoring of blood pressure among people. Also, due to integration of tele-medicine, patients themselves rely on self-monitoring of blood pressure at home. The market for cardiac monitoring devices has been segmented into various device types including electrocardiogram, holter monitors, event monitors, cardiac output monitors, and others (wrist rate monitors, strapped rate monitors, etc.). Of these, the market for electrocardiograms accounted for the largest share by revenue in 2012, at around 45%. Geographically, the market has been segmented into North America, Europe, Asia-Pacific and Rest of the World (RoW). North America led the global market for both blood and cardiac monitoring devices in 2012, in terms of revenue share. With innovations in blood monitoring making the testing much less invasive for the geriatric population and other cardiac patients, revenue for the North American market is set to skyrocket. Physicians in the region are increasingly demanding to work with the newer, less invasive or noninvasive systems, which will help in rapid growth of the minimally and non-invasive blood and cardiac monitoring markets. The fastest growth in this market will be observed in the Asia-Pacific region during the forecast period. Sedentary lifestyles and the resultant rise in the prevalence of chronic illnesses, increase in the per capita income and healthcare expenditures, improvement in healthcare infrastructure and a large pool of geriatric population are the key factors fuelling market growth in the region. The market for cardiac monitors is highly oligopolistic in nature, with the top two players accounting for the majority of the market share in 2012. Key Topics Covered - Introduction to the Report - Market Synopsis - Market Dynamics: Global Blood and Cardiac Monitoring Devices Market - Products Market Size & Forecast - Global Blood and Cardiac Monitoring Devices Market - Geography Market Size & Forecast - Global Blood and Cardiac Monitoring Devices Market - Key Players Analysis: Global Blood and Cardiac Monitoring Devices Market, 2012 (%) - Company Profiles Companies Mentioned - Dragerwerk AG & Co. - Edwards Lifesciences - GE Healthcare - ICU Medical - LiDCO - Medtronic - Mortara - Nihon Kohden - Omron - Philips Healthcare - Roche - Schiller - Spacelabs Healthcare - Welch Allyn For more information visit http://www.researchandmarkets.com/research/vz...nd_cardiac About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Upgrade Alert for Edwards Lifesciences (EW)
Comtex SmarTrend(R) - Mon Mar 10, 8:35AM CDT
Edwards Lifesciences (NYSE:EW) was upgraded from Market Perform to Outperform at Wells Fargo today. The stock closed yesterday at $72.07 on volume of 959,000 shares, below average daily volume of 1.3 million. Edwards Lifesciences Corporation designs, develops, manufactures, and markets products and services to treat late-stage cardiovascular disease. The Company's products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards supplies its products to customers located worldwide.
Medtronic Wins European Patent Fight Against Edwards
Eric Volkman, The Motley Fool - Motley Fool - Thu Mar 06, 7:56PM CST
Medtronic has won an intellectual property victory on the other side of the Atlantic Ocean. The company announced today that the European Patent Office has invalidated and revoked a patent, the Spenser, held by Edwards Lifesciences for an...
Edwards Lifesciences Announces First Human Implants With Mitral Transcatheter Valve System
Marketwire - Thu Mar 06, 8:02AM CST
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced the successful completion of the first three human implants of its FORTIS mitral transcatheter heart valve, which were performed in February and March by the Heart Team at St. Thomas' Hospital in London.
US Market for Dialysis Equipment and Concentrates
M2 - Thu Mar 06, 3:09AM CST
Research and Markets (http://www.researchandmarkets.com/research/npv4t6/u_s_market_for) has announced the addition of the "U.S. Market for Dialysis Equipment and Concentrates" report to their offering. The Total Dialysis Device And Concentrates Market Will Grow To A Value Of Almost $2 Billion By 2020 The total dialysis device and concentrates market includes the markets for hemodialysis machines, dialysis catheters, dialysis concentrates, dialyzers, dialyzer reprocessing machines, bloodlines, AV fistula needles, AV grafts, declotting devices, guidewires, introducer sheaths and water treatment systems. The market will grow as a result of increased patient populations. The patient populations of traditional incenter hemodialysis, home hemodialysis (HHD) and peritoneal dialysis are expected to grow over the forecast period. There will also be strong growth in the dry concentrates and heat disinfectant water treatment system market. Scope of the Report - Competitor Analysis - Identified Strategic Opportunities - Market Overview by Segment - Trend Analysis by Segment - Market Drivers & Limiters - Mergers & Acquisitions - Customer Feedback & Market Monitoring Reasons To Buy This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on a 'ground up' approach, which includes primary and secondary research methods. This report forecasts the development of the US market up to 2020. Key Topics Covered - Executive Summary - Research Methodology - US Dialysis Device And Concentrates Market - Hemodialysis Machine Market - Dialysis Catheter Market - Dialysis Concentrates Market - Dialyzer Market - Dialyzer Reprocessing Machine Market - Hemodialysis Bloodline And Tubing Set Market - Av Fistula Needle Market - Av Access Graft Market - Declotting Device Market - Introducer Sheath And Guidewire Market - Water Treatment System Market Companies Mentioned - AmeriWater - AngioDynamics - Argon Medical - Asahi Kasei Medical - B. Braun - Baxter - C. R. Bard - Cook Medical - Cordis - Covidien - Edwards Lifesciences - Fresenius - Gambro - Kawasumi Laboratories - LeMaitre - MAKY - MEDRAD - Mar Cor - Medcomp - Medisystems (NxStage Medical) - Medivators - NxStage Medical - Rockwell - Teleflex Medical - Terumo, - Vascular - W. L. Gore For more information visit http://www.researchandmarkets.com/research/np...market_for About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
SmarTrend Watching for Potential Pullback in Shares of Edwards Lifesciences After 3.07% Gain
Comtex SmarTrend(R) - Wed Mar 05, 5:33PM CST
Edwards Lifesciences (NYSE:EW) traded in a range yesterday that spanned from a low of $69.54 to a high of $72.62. Yesterday, the shares gained 3.1%, which took the trading range above the 3-day high of $70.83 on volume of 1.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
The European Patient Monitoring Market Expected to Experience Stable Growth over the Forecast Period, Exceeding 1.1 Billion By 2020
M2 - Tue Mar 04, 8:22AM CST
Research and Markets (http://www.researchandmarkets.com/research/5hldvr/european_markets) has announced the addition of the "European Markets for Patient Monitoring Equipment (Executive Summary)" report to their offering. This executive summary relates to the report European Markets for Patient Monitoring Equipment. The total European patient monitoring market has suffered as a consequence of the contracting European economy. The market for patient monitoring devices and equipment includes multi- parameter vital sign monitors, wireless ambulatory telemetry monitors, cardiac output monitors and consumables, electromyogram devices and consumables, electroencephalogram monitors, fetal and neonatal monitors, pulse oximetry monitors and consumables and telehealth solutions. Unit sales have remained flat or declined in most segments, as hospitals wait longer to replace existing equipment. Lower- priced competitors from Asia and Eastern Europe, have entered the market, creating a shift in demand and lowering the average selling price (ASP) in many segments.This report covers Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland and the United Kingdom. This report pertains to a forecast period of 10 years (2010 - 2020) for the European market. Countries Included: Austria, Belgium, Denmark, Finland, France, Germany, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, U.K. Scope of the Report - Competitor Analysis - Identified Strategic Opportunities - Market Overview by Segment - Trend Analysis by Segment - Market Drivers & Limiters - Mergers & Acquisitions - Customer Feedback & Market Monitoring Main Segments Included - European Patient Monitoring Market - Multi- Parameter Vital Signs Monitoring Market - Wireless Ambulatory Telemetry Monitor Market - Cardiac Output Monitoring Market - Electromyogram Monitoring Market - Fetal and Neonatal Monitoring Market - Peripheral Pulse Oximeter Market - Telehealth Monitoring Market Companies Mentioned: - Edwards Lifesciences - GE Healthcare - Philips Healthcare - Pulsion Medical For more information visit http://www.researchandmarkets.com/research/5h...an_markets About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
3 Top Health Care Dividends Every Investor Needs to Know
Dan Carroll, The Motley Fool - Motley Fool - Mon Mar 03, 5:30PM CST
What's the smartest investors' biggest secret weapon? For those with the patience to wait for the market's long-term rewards, the power of dividends can make a big difference. Dividends especially have a strong hold in the health care sector, an...
U.S. Market for Dialysis Equipment and Concentrates (Executive Summary)
M2 - Fri Feb 28, 10:28AM CST
Research and Markets (http://www.researchandmarkets.com/research/cbwzlh/u_s_market_for) has announced the addition of the U.S. Market for Dialysis Equipment and Concentrates (Executive Summary) report to their offering. This executive summary relates to the report U.S. Market for Dialysis Equipment and Concentrates. The total dialysis device and concentrates market will grow to a value of almost $2 billion over the forecast period. The total dialysis device and concentrates market includes the markets for hemodialysis machines, dialysis catheters, dialysis concentrates, dialyzers, dialyzer reprocessing machines, bloodlines, AV fistula needles, AV grafts, declotting devices, guidewires, introducer sheaths and water treatment systems. The market will grow as a result of increased patient populations. The patient populations of traditional incenter hemodialysis, home hemodialysis (HHD) and peritoneal dialysis are expected to grow over the forecast period. There will also be strong growth in the dry concentrates and heat disinfectant water treatment system market. This report pertains to a forecast period of 10 years (2010 - 2020) for the U.S. market. Scope of the Report - Competitor Analysis - Identified Strategic Opportunities - Market Overview by Segment - Trend Analysis by Segment - Market Drivers & Limiters - Mergers & Acquisitions - Customer Feedback & Market Monitoring Main Segments Included - U.S. Dialysis Device and Concentrates Market - Hemodialysis Machine Market - Dialysis Catheter Market - Dialysis Concentrates Market - Dialyzer Market - Dialyzer Reprocessing Machine Market - Hemodialysis Bloodline and Tubing Set Market - AV Fistula Needle Market - AV Access Graft Market - Declotting Device Market - Introducer Sheath and Guidewire Market - Water Treatment System Market Reasons To Buy This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on a 'ground up' approach, which includes primary and secondary research methods. * Please note this is an executive summary only. The full report is available for purchase by following the link below. Key Topics Covered: 1. Executive Summary 1.1 U.S. Dialysis Device And Concentrates Market 1.2 Hemodialysis Machine Market 1.3 Dialysis Catheter Market 1.4 Dialysis Concentrates Market 1.5 Dialyzer Market 1.6 Dialyzer Reprocessing Machine Market 1.7 Hemodialysis Bloodline And Tubing Set Market 1.8 Av Fistula Needle Market 1.9 Av Access Graft Market 1.10 Declotting Device Market 1.11 Introducer Sheath And Guidewire Market 1.12 Water Treatment System Market 1.13 Competitive Analysis Companies Mentioned: - AmeriWater - AngioDynamics - Argon Medical - Asahi Kasei Medical - B. Braun - Baxter - C. R. Bard - Cook Medical - Cordis - Covidien - Edwards Lifesciences - Fresenius - Gambro - Kawasumi Laboratories - LeMaitre - MAKY - MEDRAD - Mar Cor - Medcomp - Medisystems (NxStage Medical) - Medivators - NxStage Medical - Rockwell - Teleflex Medical - Terumo, - Vascular - W. L. Gore For more information visit http://www.researchandmarkets.com/research/cb...market_for About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
European Markets for Patient Monitoring Equipment is Forecast to Exceed 1.1 billion by 2020
M2 - Fri Feb 28, 10:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/zj9gkp/european_markets) has announced the addition of the "European Markets for Patient Monitoring Equipment" report to their offering. The market for patient monitoring devices and equipment includes multi- parameter vital sign monitors, wireless ambulatory telemetry monitors, cardiac output monitors and consumables, electromyogram devices and consumables, electroencephalogram monitors, fetal and neonatal monitors, pulse oximetry monitors and consumables and telehealth solutions. Unit sales have remained flat or declined in most segments, as hospitals wait longer to replace existing equipment. Lower- priced competitors from Asia and Eastern Europe, have entered the market, creating a shift in demand and lowering the average selling price (ASP) in many segments.This report covers Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland and the United Kingdom. This report pertains to a forecast period of 10 years (2010 - 2020) for the European market. Countries Included: Austria, Belgium, Denmark, Finland, France, Germany, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, U.K. Scope of the Report - Competitor Analysis - Identified Strategic Opportunities - Market Overview by Segment - Trend Analysis by Segment - Market Drivers & Limiters - Mergers & Acquisitions - Customer Feedback & Market Monitoring Main Segments Included - European Patient Monitoring Market - Multi- Parameter Vital Signs Monitoring Market - Wireless Ambulatory Telemetry Monitor Market - Cardiac Output Monitoring Market - Electromyogram Monitoring Market - Fetal and Neonatal Monitoring Market - Peripheral Pulse Oximeter Market - Telehealth Monitoring Market Key Topics Covered: Executive Summary European Patient Monitoring Market Overview Country Profiles Multi-Parameter Vital Signs Monitoring Market Wireless Ambulatory Telemetry Monitor Market Cardiac Output Monitoring Market Electromyogram Monitoring Market Electroencephalogram Monitoring Market Fetal And Neonatal Monitoring Market Peripheral Pulse Oximeter Market Telehealth Market Abbreviations Companies Mentioned: - Edwards Lifesciences - GE Healthcare - Philips Healthcare - Pulsion Medical For more information visit http://www.researchandmarkets.com/research/zj...an_markets About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Can Abbott Laboratories Beat Baxter International and Edwards Lifesciences in 2014?
Peter Stephens, The Motley Fool - Motley Fool - Wed Feb 26, 3:31PM CST
The year 2013 proved to be a rather frustrating one for shareholders in Abbott Laboratories . Indeed, shares were outperformed by the S&P 500, with the index delivering capital gains of 32% while Abbott Laboratories managed only 19%. However,...
Multiple Setbacks May Spell Opportunity at Medtronic, Inc.
Stephen D., Simpson,, The Motley Fool - Motley Fool - Thu Feb 20, 1:30PM CST
In a pretty richly valued med-tech space, it takes some setbacks to uncover value and opportunity. Medtronic has certainly seen setbacks, as the company has abandoned renal denervation, has lost some momentum in CRM, and may not be as competitive...
Jim Cramer's 'Mad Money' CEO Chats: Edwards Lifesciences and Galena Biopharma
at The Street - Wed Feb 19, 5:00AM CST
Jim Cramer talks to the CEOs of two companies representing the big and small sides of health care in America.
Global Central Venous Access Devices Market 2014-2018: Becton, Dickinson and Co., Cook Medical Inc., C.R Bard Inc. and Teleflex Inc Among Top Vendors
M2 - Mon Feb 17, 9:23AM CST
Research and Markets (http://www.researchandmarkets.com/research/4268p7/global_central) has announced the addition of the "Global Central Venous Access Devices Market 2014-2018" report to their offering. The analysts forecast the Global Central Venous Access Devices market to grow at a CAGR of 4.10 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing aging population. The Global Central Venous Access Devices market has also been witnessing the increased use of antimicrobial catheters. However, the high risk of vein thrombosis could pose a challenge to the growth of this market. Key vendors dominating this space are AngioDynamics Inc., B. Braun Melsungen AG, Becton, Dickinson and Co., Cook Medical Inc., C.R Bard Inc., and Teleflex Inc. Other vendors mentioned in the report are Boston Scientific Corp., Covidien Plc., Edwards Lifesciences Corp., Medical Components Inc., Smiths Medical, Terumo Corp., and Vygon Corp. Commenting on the report, an analyst from the team said: Following the change of reimbursement policies (offered under Medicare and Medicaid) in the recent past, there has been an increase in the use of antimicrobial catheters. According to the changes, reimbursement would no longer be provided for treatment of vascular access-related infections acquired during a patient's hospitalization. The antimicrobial CVCs are inserted directly into the bloodstream through the large internal jugular, subclavian, and femoral veins, making them highly susceptible to infection. The complete CVC kits include maximum barrier drapes, manufactured catheter securement devices, and the antimicrobial agent (chlorhexidine) that is highly adopted by surgeons. The demand for dialysis catheters with intraluminal antimicrobial properties has also increased over the years. In addition, antimicrobial PICCs are extensively used to deliver chemotherapy and antibiotics as well as for drawing blood from immunocompromised patients. According to the report, one of the main drivers in this market is the increasing aging population that has led to an increase in demand for central venous access devices for delivering drugs, nutritional support, or aspiration of blood for sampling. For more information visit http://www.researchandmarkets.com/research/42...al_central About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Edwards Life (EW) Flagged As A Storm The Castle Stock
at The Street - Fri Feb 14, 10:04AM CST
Trade-Ideas LLC identified Edwards Life (EW) as a "storm the castle" (crossing above the 200-day simple moving average on higher than normal relative volume) candidate
Global Transcatheter Aortic Valve Replacement (TAVR) Market Report: 2013 Edition
M2 - Tue Feb 11, 4:10AM CST
Research and Markets (http://www.researchandmarkets.com/research/jz3fpf/global) has announced the addition of the "Global Transcatheter Aortic Valve Replacement (TAVR) Market Report: 2013 Edition" report to their offering. The Transcatheter Aortic Valve Replacement (TAVR) is a relatively new technology in medical science which is a less invasive method of replacing the heart valve without undergoing the conventional by-pass surgery. Traditionally, the aortic valve replacement has required open heart surgery, thus disqualifying patients who are at high risk for the process or are too weak to undergo a surgery. Partially for this reason, the market of heart valve surgical procedure is witnessing a continuous decline as more and more patients requiring valve replacement are at high risk for a surgical treatment. This shortcoming of traditional surgery has paved the way for growth of TAVR. It was first commercially launched in Europe in 2007 and later in the United States. The market is very promising and has lot of opportunities and unmet demand to cater to. Economic growth worldwide, rising income and wealth levels, increasing ageing population and continuously increasing obese population are fueling the development of the global TAVR market. The growth of the TAVR market has high correlation with macro indicators, such as global GDP, and global healthcare expenditure. This report analyzes the development of the "global TAVR market", with focus on some of the major markets like the United States and Europe. The major trends, drivers facilitating growth of the TAVR market as well as the issues being faced by the industry are being presented in this report. Key Topics Covered 1. Market Overview 2. TAVR Market Size 2.1 TAVR Market: Regional Analysis 3. Market Dynamics 3.1 Key Trends 3.2 Growth Drivers 3.3 Challenges 3.4 Significant Developments 4. Competitive Landscape 4.1 The US 4.2 Europe 5. Company Profiles 6. Market Outlook 6.1 Market Forecast 6.2 Forecast Methodology Companies Mentioned - Edwards Lifesciences - Medtronic - St. Jude Medical For more information visit http://www.researchandmarkets.com/research/jz3fpf/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
Edwards' SAPIEN XT Valve Approved in Europe for Transcatheter Mitral and Aortic Valve-in-Valve Procedures
Marketwire - Wed Feb 05, 8:16AM CST
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced it has received CE Mark in Europe for valve-in-valve procedures using the SAPIEN XT transcatheter heart valve, providing a minimally invasive treatment option for patients whose surgical mitral or aortic valves require replacement, and who are at extreme risk for surgery. Edwards is the only company to receive a valve-in-valve indication for the mitral position, which addresses an unmet need within the clinical community to provide an alternative to a high-risk surgery.
Edwards Lifesciences Corp. Still Trying To Regain Footing
Stephen D., Simpson,, The Motley Fool - Motley Fool - Tue Feb 04, 5:30PM CST
Transcatheter valves still make up one of the relatively few therapeutic areas in med-tech that is both large and growing at a significant rate. That does not mean that it's all downhill for Edwards Lifesciences , however, as the company continues...
SmarTrend Watching for Potential Pullback in Shares of Edwards Lifesciences After 2.45% Gain
Comtex SmarTrend(R) - Tue Feb 04, 4:38PM CST
Edwards Lifesciences (NYSE:EW) traded in a range yesterday that spanned from a low of $63.25 to a high of $66.20. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $65.98 on volume of 3.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Q4 Earnings Beat at Edwards, Revs in Line - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 04, 8:50AM CST
Edwards Lifesciences' fourth-quarter 2013 adjusted EPS rose 1.1% year over year to 91 cents.
Blood and Cardiac Monitoring Devices Market Assessment Report - Global Size, Share, Competitive Landscape, Future Prospects and Forecast from 2013-2019
M2 - Thu Mar 13, 3:48AM CDT
Research and Markets (http://www.researchandmarkets.com/research/vzjflp/blood_and_cardiac) has announced the addition of the "Blood and Cardiac Monitoring Devices Market Assessment Report - Global Size, Share, Competitive Landscape, Future Prospects and Forecast from 2013-2019" report to their offering. According to the report the global blood and cardiac monitoring devices market was worth $13.6 billion in 2012 and is expected to reach $20.5 billion in 2019, growing at a CAGR of 6.0% from 2013 to 2019. The market for blood monitoring devices is segmented into blood pressure monitors, blood glucose monitors, blood gas analyzers and blood cholesterol monitors. In 2012, the market for blood glucose monitors accounted for the largest share by revenue of the total market at more than 70%. This is attributed mainly to the consistent technological up-gradations in product design followed by the alarming rise in diabetic population and sedentary lifestyles. However, the blood pressure monitors market is expected to record the highest growth during the forecast period owing to the rising prevalence and incidence rate of hypertension and increased awareness about regular monitoring of blood pressure among people. Also, due to integration of tele-medicine, patients themselves rely on self-monitoring of blood pressure at home. The market for cardiac monitoring devices has been segmented into various device types including electrocardiogram, holter monitors, event monitors, cardiac output monitors, and others (wrist rate monitors, strapped rate monitors, etc.). Of these, the market for electrocardiograms accounted for the largest share by revenue in 2012, at around 45%. Geographically, the market has been segmented into North America, Europe, Asia-Pacific and Rest of the World (RoW). North America led the global market for both blood and cardiac monitoring devices in 2012, in terms of revenue share. With innovations in blood monitoring making the testing much less invasive for the geriatric population and other cardiac patients, revenue for the North American market is set to skyrocket. Physicians in the region are increasingly demanding to work with the newer, less invasive or noninvasive systems, which will help in rapid growth of the minimally and non-invasive blood and cardiac monitoring markets. The fastest growth in this market will be observed in the Asia-Pacific region during the forecast period. Sedentary lifestyles and the resultant rise in the prevalence of chronic illnesses, increase in the per capita income and healthcare expenditures, improvement in healthcare infrastructure and a large pool of geriatric population are the key factors fuelling market growth in the region. The market for cardiac monitors is highly oligopolistic in nature, with the top two players accounting for the majority of the market share in 2012. Key Topics Covered - Introduction to the Report - Market Synopsis - Market Dynamics: Global Blood and Cardiac Monitoring Devices Market - Products Market Size & Forecast - Global Blood and Cardiac Monitoring Devices Market - Geography Market Size & Forecast - Global Blood and Cardiac Monitoring Devices Market - Key Players Analysis: Global Blood and Cardiac Monitoring Devices Market, 2012 (%) - Company Profiles Companies Mentioned - Dragerwerk AG & Co. - Edwards Lifesciences - GE Healthcare - ICU Medical - LiDCO - Medtronic - Mortara - Nihon Kohden - Omron - Philips Healthcare - Roche - Schiller - Spacelabs Healthcare - Welch Allyn For more information visit http://www.researchandmarkets.com/research/vz...nd_cardiac About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Upgrade Alert for Edwards Lifesciences (EW)
Comtex SmarTrend(R) - Mon Mar 10, 8:35AM CDT
Edwards Lifesciences (NYSE:EW) was upgraded from Market Perform to Outperform at Wells Fargo today. The stock closed yesterday at $72.07 on volume of 959,000 shares, below average daily volume of 1.3 million. Edwards Lifesciences Corporation designs, develops, manufactures, and markets products and services to treat late-stage cardiovascular disease. The Company's products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards supplies its products to customers located worldwide.
Medtronic Wins European Patent Fight Against Edwards
Eric Volkman, The Motley Fool - Motley Fool - Thu Mar 06, 7:56PM CST
Medtronic has won an intellectual property victory on the other side of the Atlantic Ocean. The company announced today that the European Patent Office has invalidated and revoked a patent, the Spenser, held by Edwards Lifesciences for an...
Edwards Lifesciences Announces First Human Implants With Mitral Transcatheter Valve System
Marketwire - Thu Mar 06, 8:02AM CST
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced the successful completion of the first three human implants of its FORTIS mitral transcatheter heart valve, which were performed in February and March by the Heart Team at St. Thomas' Hospital in London.
US Market for Dialysis Equipment and Concentrates
M2 - Thu Mar 06, 3:09AM CST
Research and Markets (http://www.researchandmarkets.com/research/npv4t6/u_s_market_for) has announced the addition of the "U.S. Market for Dialysis Equipment and Concentrates" report to their offering. The Total Dialysis Device And Concentrates Market Will Grow To A Value Of Almost $2 Billion By 2020 The total dialysis device and concentrates market includes the markets for hemodialysis machines, dialysis catheters, dialysis concentrates, dialyzers, dialyzer reprocessing machines, bloodlines, AV fistula needles, AV grafts, declotting devices, guidewires, introducer sheaths and water treatment systems. The market will grow as a result of increased patient populations. The patient populations of traditional incenter hemodialysis, home hemodialysis (HHD) and peritoneal dialysis are expected to grow over the forecast period. There will also be strong growth in the dry concentrates and heat disinfectant water treatment system market. Scope of the Report - Competitor Analysis - Identified Strategic Opportunities - Market Overview by Segment - Trend Analysis by Segment - Market Drivers & Limiters - Mergers & Acquisitions - Customer Feedback & Market Monitoring Reasons To Buy This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on a 'ground up' approach, which includes primary and secondary research methods. This report forecasts the development of the US market up to 2020. Key Topics Covered - Executive Summary - Research Methodology - US Dialysis Device And Concentrates Market - Hemodialysis Machine Market - Dialysis Catheter Market - Dialysis Concentrates Market - Dialyzer Market - Dialyzer Reprocessing Machine Market - Hemodialysis Bloodline And Tubing Set Market - Av Fistula Needle Market - Av Access Graft Market - Declotting Device Market - Introducer Sheath And Guidewire Market - Water Treatment System Market Companies Mentioned - AmeriWater - AngioDynamics - Argon Medical - Asahi Kasei Medical - B. Braun - Baxter - C. R. Bard - Cook Medical - Cordis - Covidien - Edwards Lifesciences - Fresenius - Gambro - Kawasumi Laboratories - LeMaitre - MAKY - MEDRAD - Mar Cor - Medcomp - Medisystems (NxStage Medical) - Medivators - NxStage Medical - Rockwell - Teleflex Medical - Terumo, - Vascular - W. L. Gore For more information visit http://www.researchandmarkets.com/research/np...market_for About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
SmarTrend Watching for Potential Pullback in Shares of Edwards Lifesciences After 3.07% Gain
Comtex SmarTrend(R) - Wed Mar 05, 5:33PM CST
Edwards Lifesciences (NYSE:EW) traded in a range yesterday that spanned from a low of $69.54 to a high of $72.62. Yesterday, the shares gained 3.1%, which took the trading range above the 3-day high of $70.83 on volume of 1.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
The European Patient Monitoring Market Expected to Experience Stable Growth over the Forecast Period, Exceeding 1.1 Billion By 2020
M2 - Tue Mar 04, 8:22AM CST
Research and Markets (http://www.researchandmarkets.com/research/5hldvr/european_markets) has announced the addition of the "European Markets for Patient Monitoring Equipment (Executive Summary)" report to their offering. This executive summary relates to the report European Markets for Patient Monitoring Equipment. The total European patient monitoring market has suffered as a consequence of the contracting European economy. The market for patient monitoring devices and equipment includes multi- parameter vital sign monitors, wireless ambulatory telemetry monitors, cardiac output monitors and consumables, electromyogram devices and consumables, electroencephalogram monitors, fetal and neonatal monitors, pulse oximetry monitors and consumables and telehealth solutions. Unit sales have remained flat or declined in most segments, as hospitals wait longer to replace existing equipment. Lower- priced competitors from Asia and Eastern Europe, have entered the market, creating a shift in demand and lowering the average selling price (ASP) in many segments.This report covers Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland and the United Kingdom. This report pertains to a forecast period of 10 years (2010 - 2020) for the European market. Countries Included: Austria, Belgium, Denmark, Finland, France, Germany, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, U.K. Scope of the Report - Competitor Analysis - Identified Strategic Opportunities - Market Overview by Segment - Trend Analysis by Segment - Market Drivers & Limiters - Mergers & Acquisitions - Customer Feedback & Market Monitoring Main Segments Included - European Patient Monitoring Market - Multi- Parameter Vital Signs Monitoring Market - Wireless Ambulatory Telemetry Monitor Market - Cardiac Output Monitoring Market - Electromyogram Monitoring Market - Fetal and Neonatal Monitoring Market - Peripheral Pulse Oximeter Market - Telehealth Monitoring Market Companies Mentioned: - Edwards Lifesciences - GE Healthcare - Philips Healthcare - Pulsion Medical For more information visit http://www.researchandmarkets.com/research/5h...an_markets About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
3 Top Health Care Dividends Every Investor Needs to Know
Dan Carroll, The Motley Fool - Motley Fool - Mon Mar 03, 5:30PM CST
What's the smartest investors' biggest secret weapon? For those with the patience to wait for the market's long-term rewards, the power of dividends can make a big difference. Dividends especially have a strong hold in the health care sector, an...
U.S. Market for Dialysis Equipment and Concentrates (Executive Summary)
M2 - Fri Feb 28, 10:28AM CST
Research and Markets (http://www.researchandmarkets.com/research/cbwzlh/u_s_market_for) has announced the addition of the U.S. Market for Dialysis Equipment and Concentrates (Executive Summary) report to their offering. This executive summary relates to the report U.S. Market for Dialysis Equipment and Concentrates. The total dialysis device and concentrates market will grow to a value of almost $2 billion over the forecast period. The total dialysis device and concentrates market includes the markets for hemodialysis machines, dialysis catheters, dialysis concentrates, dialyzers, dialyzer reprocessing machines, bloodlines, AV fistula needles, AV grafts, declotting devices, guidewires, introducer sheaths and water treatment systems. The market will grow as a result of increased patient populations. The patient populations of traditional incenter hemodialysis, home hemodialysis (HHD) and peritoneal dialysis are expected to grow over the forecast period. There will also be strong growth in the dry concentrates and heat disinfectant water treatment system market. This report pertains to a forecast period of 10 years (2010 - 2020) for the U.S. market. Scope of the Report - Competitor Analysis - Identified Strategic Opportunities - Market Overview by Segment - Trend Analysis by Segment - Market Drivers & Limiters - Mergers & Acquisitions - Customer Feedback & Market Monitoring Main Segments Included - U.S. Dialysis Device and Concentrates Market - Hemodialysis Machine Market - Dialysis Catheter Market - Dialysis Concentrates Market - Dialyzer Market - Dialyzer Reprocessing Machine Market - Hemodialysis Bloodline and Tubing Set Market - AV Fistula Needle Market - AV Access Graft Market - Declotting Device Market - Introducer Sheath and Guidewire Market - Water Treatment System Market Reasons To Buy This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on a 'ground up' approach, which includes primary and secondary research methods. * Please note this is an executive summary only. The full report is available for purchase by following the link below. Key Topics Covered: 1. Executive Summary 1.1 U.S. Dialysis Device And Concentrates Market 1.2 Hemodialysis Machine Market 1.3 Dialysis Catheter Market 1.4 Dialysis Concentrates Market 1.5 Dialyzer Market 1.6 Dialyzer Reprocessing Machine Market 1.7 Hemodialysis Bloodline And Tubing Set Market 1.8 Av Fistula Needle Market 1.9 Av Access Graft Market 1.10 Declotting Device Market 1.11 Introducer Sheath And Guidewire Market 1.12 Water Treatment System Market 1.13 Competitive Analysis Companies Mentioned: - AmeriWater - AngioDynamics - Argon Medical - Asahi Kasei Medical - B. Braun - Baxter - C. R. Bard - Cook Medical - Cordis - Covidien - Edwards Lifesciences - Fresenius - Gambro - Kawasumi Laboratories - LeMaitre - MAKY - MEDRAD - Mar Cor - Medcomp - Medisystems (NxStage Medical) - Medivators - NxStage Medical - Rockwell - Teleflex Medical - Terumo, - Vascular - W. L. Gore For more information visit http://www.researchandmarkets.com/research/cb...market_for About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
European Markets for Patient Monitoring Equipment is Forecast to Exceed 1.1 billion by 2020
M2 - Fri Feb 28, 10:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/zj9gkp/european_markets) has announced the addition of the "European Markets for Patient Monitoring Equipment" report to their offering. The market for patient monitoring devices and equipment includes multi- parameter vital sign monitors, wireless ambulatory telemetry monitors, cardiac output monitors and consumables, electromyogram devices and consumables, electroencephalogram monitors, fetal and neonatal monitors, pulse oximetry monitors and consumables and telehealth solutions. Unit sales have remained flat or declined in most segments, as hospitals wait longer to replace existing equipment. Lower- priced competitors from Asia and Eastern Europe, have entered the market, creating a shift in demand and lowering the average selling price (ASP) in many segments.This report covers Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland and the United Kingdom. This report pertains to a forecast period of 10 years (2010 - 2020) for the European market. Countries Included: Austria, Belgium, Denmark, Finland, France, Germany, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, U.K. Scope of the Report - Competitor Analysis - Identified Strategic Opportunities - Market Overview by Segment - Trend Analysis by Segment - Market Drivers & Limiters - Mergers & Acquisitions - Customer Feedback & Market Monitoring Main Segments Included - European Patient Monitoring Market - Multi- Parameter Vital Signs Monitoring Market - Wireless Ambulatory Telemetry Monitor Market - Cardiac Output Monitoring Market - Electromyogram Monitoring Market - Fetal and Neonatal Monitoring Market - Peripheral Pulse Oximeter Market - Telehealth Monitoring Market Key Topics Covered: Executive Summary European Patient Monitoring Market Overview Country Profiles Multi-Parameter Vital Signs Monitoring Market Wireless Ambulatory Telemetry Monitor Market Cardiac Output Monitoring Market Electromyogram Monitoring Market Electroencephalogram Monitoring Market Fetal And Neonatal Monitoring Market Peripheral Pulse Oximeter Market Telehealth Market Abbreviations Companies Mentioned: - Edwards Lifesciences - GE Healthcare - Philips Healthcare - Pulsion Medical For more information visit http://www.researchandmarkets.com/research/zj...an_markets About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Can Abbott Laboratories Beat Baxter International and Edwards Lifesciences in 2014?
Peter Stephens, The Motley Fool - Motley Fool - Wed Feb 26, 3:31PM CST
The year 2013 proved to be a rather frustrating one for shareholders in Abbott Laboratories . Indeed, shares were outperformed by the S&P 500, with the index delivering capital gains of 32% while Abbott Laboratories managed only 19%. However,...
Multiple Setbacks May Spell Opportunity at Medtronic, Inc.
Stephen D., Simpson,, The Motley Fool - Motley Fool - Thu Feb 20, 1:30PM CST
In a pretty richly valued med-tech space, it takes some setbacks to uncover value and opportunity. Medtronic has certainly seen setbacks, as the company has abandoned renal denervation, has lost some momentum in CRM, and may not be as competitive...
Jim Cramer's 'Mad Money' CEO Chats: Edwards Lifesciences and Galena Biopharma
at The Street - Wed Feb 19, 5:00AM CST
Jim Cramer talks to the CEOs of two companies representing the big and small sides of health care in America.
Global Central Venous Access Devices Market 2014-2018: Becton, Dickinson and Co., Cook Medical Inc., C.R Bard Inc. and Teleflex Inc Among Top Vendors
M2 - Mon Feb 17, 9:23AM CST
Research and Markets (http://www.researchandmarkets.com/research/4268p7/global_central) has announced the addition of the "Global Central Venous Access Devices Market 2014-2018" report to their offering. The analysts forecast the Global Central Venous Access Devices market to grow at a CAGR of 4.10 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing aging population. The Global Central Venous Access Devices market has also been witnessing the increased use of antimicrobial catheters. However, the high risk of vein thrombosis could pose a challenge to the growth of this market. Key vendors dominating this space are AngioDynamics Inc., B. Braun Melsungen AG, Becton, Dickinson and Co., Cook Medical Inc., C.R Bard Inc., and Teleflex Inc. Other vendors mentioned in the report are Boston Scientific Corp., Covidien Plc., Edwards Lifesciences Corp., Medical Components Inc., Smiths Medical, Terumo Corp., and Vygon Corp. Commenting on the report, an analyst from the team said: Following the change of reimbursement policies (offered under Medicare and Medicaid) in the recent past, there has been an increase in the use of antimicrobial catheters. According to the changes, reimbursement would no longer be provided for treatment of vascular access-related infections acquired during a patient's hospitalization. The antimicrobial CVCs are inserted directly into the bloodstream through the large internal jugular, subclavian, and femoral veins, making them highly susceptible to infection. The complete CVC kits include maximum barrier drapes, manufactured catheter securement devices, and the antimicrobial agent (chlorhexidine) that is highly adopted by surgeons. The demand for dialysis catheters with intraluminal antimicrobial properties has also increased over the years. In addition, antimicrobial PICCs are extensively used to deliver chemotherapy and antibiotics as well as for drawing blood from immunocompromised patients. According to the report, one of the main drivers in this market is the increasing aging population that has led to an increase in demand for central venous access devices for delivering drugs, nutritional support, or aspiration of blood for sampling. For more information visit http://www.researchandmarkets.com/research/42...al_central About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Edwards Life (EW) Flagged As A Storm The Castle Stock
at The Street - Fri Feb 14, 10:04AM CST
Trade-Ideas LLC identified Edwards Life (EW) as a "storm the castle" (crossing above the 200-day simple moving average on higher than normal relative volume) candidate
Global Transcatheter Aortic Valve Replacement (TAVR) Market Report: 2013 Edition
M2 - Tue Feb 11, 4:10AM CST
Research and Markets (http://www.researchandmarkets.com/research/jz3fpf/global) has announced the addition of the "Global Transcatheter Aortic Valve Replacement (TAVR) Market Report: 2013 Edition" report to their offering. The Transcatheter Aortic Valve Replacement (TAVR) is a relatively new technology in medical science which is a less invasive method of replacing the heart valve without undergoing the conventional by-pass surgery. Traditionally, the aortic valve replacement has required open heart surgery, thus disqualifying patients who are at high risk for the process or are too weak to undergo a surgery. Partially for this reason, the market of heart valve surgical procedure is witnessing a continuous decline as more and more patients requiring valve replacement are at high risk for a surgical treatment. This shortcoming of traditional surgery has paved the way for growth of TAVR. It was first commercially launched in Europe in 2007 and later in the United States. The market is very promising and has lot of opportunities and unmet demand to cater to. Economic growth worldwide, rising income and wealth levels, increasing ageing population and continuously increasing obese population are fueling the development of the global TAVR market. The growth of the TAVR market has high correlation with macro indicators, such as global GDP, and global healthcare expenditure. This report analyzes the development of the "global TAVR market", with focus on some of the major markets like the United States and Europe. The major trends, drivers facilitating growth of the TAVR market as well as the issues being faced by the industry are being presented in this report. Key Topics Covered 1. Market Overview 2. TAVR Market Size 2.1 TAVR Market: Regional Analysis 3. Market Dynamics 3.1 Key Trends 3.2 Growth Drivers 3.3 Challenges 3.4 Significant Developments 4. Competitive Landscape 4.1 The US 4.2 Europe 5. Company Profiles 6. Market Outlook 6.1 Market Forecast 6.2 Forecast Methodology Companies Mentioned - Edwards Lifesciences - Medtronic - St. Jude Medical For more information visit http://www.researchandmarkets.com/research/jz3fpf/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
Edwards' SAPIEN XT Valve Approved in Europe for Transcatheter Mitral and Aortic Valve-in-Valve Procedures
Marketwire - Wed Feb 05, 8:16AM CST
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced it has received CE Mark in Europe for valve-in-valve procedures using the SAPIEN XT transcatheter heart valve, providing a minimally invasive treatment option for patients whose surgical mitral or aortic valves require replacement, and who are at extreme risk for surgery. Edwards is the only company to receive a valve-in-valve indication for the mitral position, which addresses an unmet need within the clinical community to provide an alternative to a high-risk surgery.
Edwards Lifesciences Corp. Still Trying To Regain Footing
Stephen D., Simpson,, The Motley Fool - Motley Fool - Tue Feb 04, 5:30PM CST
Transcatheter valves still make up one of the relatively few therapeutic areas in med-tech that is both large and growing at a significant rate. That does not mean that it's all downhill for Edwards Lifesciences , however, as the company continues...
SmarTrend Watching for Potential Pullback in Shares of Edwards Lifesciences After 2.45% Gain
Comtex SmarTrend(R) - Tue Feb 04, 4:38PM CST
Edwards Lifesciences (NYSE:EW) traded in a range yesterday that spanned from a low of $63.25 to a high of $66.20. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $65.98 on volume of 3.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Q4 Earnings Beat at Edwards, Revs in Line - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 04, 8:50AM CST
Edwards Lifesciences' fourth-quarter 2013 adjusted EPS rose 1.1% year over year to 91 cents.
